Radiesse vs Sculptra: Choosing the Right Collagen Stimulator

Ashley Harwyn, PA-C, ABAAHP  |  Published February 25, 2026  |  Last updated October 6, 2026  |  20 min read

One corrects at the visit, the other builds over a course of sessions. Here is how the FDA trials compare them on areas, timing, durability and risk.

We offer Radiesse at our practice, so we have a stake in one side of this comparison. That is the reason this guide leans on the FDA's own trial summaries and labeling for both products, plus independent reviews, rather than on either company's brochures. You will find what each product is, where each is approved, how quickly it works and how long the trials followed it, what the collagen research really shows (and who paid for it), the risks, and who tends to fit which.

• Radiesse is calcium hydroxylapatite microspheres in a gel. Sculptra is poly-L-lactic acid powder that is mixed with sterile water before injection.[4][6]
• Radiesse labeling calls for a 1:1 correction with no overfilling. Sculptra labeling calls for under-correction, and its early fullness is swelling and water that usually fade within hours to a few days.[4][7]
• Sculptra is a course: up to four sessions three to four weeks apart, typically three. The Radiesse jawline trial used one treatment plus an optional touch-up four weeks later.[3][7]
• In the cheek trial, 76.9% of Sculptra patients followed to month 24 still met the improvement bar. In the jawline trial, 67.3% of Radiesse responders still did at 48 weeks. Different scales and areas, so this is not a fair race.[3][6]
• Both makers are connected to collagen research on their own product, through funding or author affiliations, and systematic reviewers call the evidence for each limited or low quality.[8][9][10]
• Sculptra's signature risk is lumps that can appear months later. Radiesse is contraindicated with bleeding disorders and shows up on CT scans.[4][5]

What is the actual difference between Radiesse and Sculptra?

Start with what is in the syringe. Radiesse is an opaque, semi-solid implant whose main ingredient is synthetic calcium hydroxylapatite, in particles 25 to 45 microns across, carried in a gel of glycerin, sodium carboxymethylcellulose and sterile water.[4] Because the gel gives the product body as it goes in, the injector places about the amount of correction they want you to leave with. The labeling calls for a 1:1 correction factor and warns against overfilling, since the treated depression should keep improving over several weeks.[4]

Sculptra starts as a dry powder in a glass vial: microparticles of poly-L-lactic acid (PLLA) with sodium carboxymethylcellulose and mannitol. Right before treatment, the injector mixes it with 5 or 8 mL of sterile water to make a suspension.[6] PLLA is a biodegradable synthetic polymer. There is no gel body doing the lifting here. The FDA-reviewed patient labeling is blunt about it: each session should under-correct the area, and any fullness you see that day comes from swelling and the water used to mix the product.[7]

That leads to the most common surprise with Sculptra. The labeling says the early fullness usually resolves within several hours to a few days, and you may look as you did before treatment. Visible correction then appears slowly over several weeks.[7] If no one warns you about that dip, it is easy to assume the treatment failed. The labeling's point is that the same-day fullness was never the result.

Both products are often called “biostimulatory,” meaning they are meant to prompt a tissue response, including new collagen, rather than only taking up space. How strong that evidence is gets its own section below. Neither material disappears quickly. In rabbits, Sculptra particles were still visible more than a year after injection, and the time it takes to break down in people is not known.[7] In Radiesse's early animal testing, calcium hydroxylapatite particles stayed in place through 36 months, with breakdown only beginning in some samples at 25 and 36 months.[2]

Where is each one FDA-approved to be used?

The FDA approves fillers for specific uses in specific areas, not for “the face” in general, and it notes that it may not have reviewed every filler for every location.[1] Radiesse and Sculptra overlap on one area, the lines from nose to mouth, and then go separate ways. Here is how they line up, side by side.

Two details in that table are easy to miss. Sculptra's cheek approval, granted in 2023, covers fine lines and wrinkles in the cheek region, not a general “volume” indication.[6] And Radiesse (+) is the version with lidocaine, a numbing medicine, which is the one approved for the jawline.[3]

Some areas are outside both labels. The FDA recommends against filler injection in the area between the eyebrows, the nose, around the eyes, the forehead and the neck.[1] Neither product is labeled for the temples or the lips, and Radiesse labeling notes published reports of nodules after lip injection.[4] Sculptra's postmarket reports include vision loss after injection into the temple, around the eyes, or the cheek.[6] Before you agree to any area, ask whether it is on that product's label. Our Radiesse page spells out which uses are approved and which are off-label.

How fast does each work, and how many sessions will you need?

Radiesse is the shorter path in visits. In the original 2006 nasolabial fold trial, patients could have up to three injections in the first phase (weeks 0, 2 and 4), with the correction checked two weeks after each.[2] The 2021 jawline trial used a single treatment, with a touch-up allowed four weeks later if needed.[3] On a 6-point wrinkle scale, the Radiesse-treated folds in the 2006 trial went from an average of 3.4 at baseline to 1.9 at three months, while folds treated with the collagen comparator sat at 3.5.[2]

Sculptra asks for more time and more visits. The labeling says the result is not immediate, that your injector should see you again in three or more weeks to decide on more product, and that most people need one to four sessions, typically three.[7] Trial patients averaged 3.2 sessions for nasolabial folds and 3.6 sessions in the cheek trial.[5][6] A three-session course spaced three to four weeks apart runs about six to eight weeks from first to last visit, and visible change builds after that.

How a Sculptra course usually runs, per its labeling

• Session one: a deliberately light treatment, then massage of the area and an ice pack wrapped in cloth.[7]
• The next five days: massage the treated area for five minutes, five times a day.[7]
• About three to four weeks later: a check to decide whether another session is needed, repeated up to four sessions.[7]
• The weeks after the last session: correction appears gradually rather than all at once.[7]

Downtime is short for both. Radiesse labeling describes procedure reactions as mainly short-lived bruising, redness and swelling lasting under seven days.[4] Sculptra labeling says most people can return to their activities right away and may apply makeup a few hours later if there is no open wound or bleeding.[7] In the Sculptra cheek trial, the median time before patients felt comfortable socializing ranged from about 4 to 7 hours across sessions.[6] The FDA notes that swelling and bruising after filler often resolve within a few days to weeks, so leave a cushion before big events.[1]

Not sure your schedule suits a slow-build treatment? Call 843-981-0870. Ask to look at the area together, go over what is on label, and map out how many visits a plan would take before you commit.

How long do Radiesse and Sculptra last, according to the FDA trials?

The older version of this page said Radiesse “typically lasts twelve to eighteen months” and that Sculptra lasted “up to two years or longer.” Those round numbers hide how the trials actually measured duration. Each trial picked an area, a rating scale and a bar for “improved,” then counted how many people stayed over the bar. Here is what they found.

Radiesse. The 2006 nasolabial fold trial followed patients for six months. At that point, 78.6% of Radiesse-treated folds scored at least one point better than the patient's other fold, which had received a collagen filler.[2] The 2021 jawline trial ran longer. At week 12, 75.6% of treated patients met the improvement bar, compared with 8.8% of an untreated group. Among the responders, 67.3% still met it at 48 weeks, before any retreatment was offered.[3] So roughly one in three early responders had slipped below the bar within the first year.

Sculptra. The 2009 nasolabial fold trial compared Sculptra with a collagen filler for 13 months, then followed Sculptra patients to 25 months, with 105 of 106 receiving no further treatment.[5] The improvement held through 19 and 25 months for folds that started shallow or moderate. For the deepest folds, the gain faded: by month 25 the average change from baseline was small and no longer statistically significant.[5] The patient labeling sums it up honestly: results lasted up to 25 months for some subjects, and improvement depended on how severe the fold was to begin with.[7]

The 2023 cheek trial is the cleanest Sculptra data. At month 12, 70.7% of treated patients met the improvement bar, compared with 25.9% of an untreated group. Treated patients who joined the extension received no more product, and 76.9% of the 65 followed were still responders at months 21 and 24.[6] That is a strong showing for fine cheek lines, earned with an average of 3.6 sessions.[6]

What can you fairly conclude? Sculptra's trials followed patients longer, out to about two years, and Radiesse's newest facial trial stopped near one year. That does not prove Sculptra lasts twice as long, because the areas, scales and comparison groups differ. Your own result depends on the area, how much product is used, and how your tissue responds. Our guide to how long dermal filler lasts covers durability across all filler families, including hyaluronic acid.

Does Radiesse or Sculptra build more collagen?

Both products are described as biostimulators, and both makers are connected to research that favors their own product: Merz funded the main calcium hydroxylapatite review, and six of the seven authors of the head-to-head gene study list Galderma affiliations.[9][10] That does not make the research wrong. It does mean you should know who is behind it.

On the Radiesse side, a 2023 systematic review of calcium hydroxylapatite pooled 12 studies: six in people, three in animals and three in lab-grown cells. Most reported more collagen after treatment. The authors still concluded that current evidence is limited, flagged methodological concerns, and said the findings should be read with caution. The review was funded by Merz, which makes Radiesse.[9]

On the Sculptra side, a 2024 systematic review of 11 randomized trials found that PLLA improved skin thickness and facial fat-loss scores, with effects lasting at least 25 months in some studies. It also found that five of the 11 trials carried a high risk of bias and that the evidence overall is low quality. Two of its authors disclosed speaking for Galderma, which makes Sculptra.[8]

For this update we searched PubMed for studies comparing the two products directly. The only head-to-head comparison of skin biology in people that it returned is one small randomized study (its team reported it in two papers). In 2025, researchers randomized 21 people with shallow nasolabial folds to compare PLLA and CaHA, then analyzed skin biopsies taken at baseline and at 90 days. They reported that PLLA switched on more genes tied to tissue repair, while CaHA switched on more genes tied to inflammation.[10] Six of the seven authors list Galderma or its Alastin subsidiary as their affiliation.[10] Gene activity in a biopsy is also not the same as a result you can see in the mirror.

Our reading: the reviews above suggest both products provoke a tissue response, and both have controlled trials showing visible improvement on blinded rating scales.[3][6][8][9] The one independent clinical trial in that search that included both products was a 2018 Spanish trial of 147 people with HIV-related facial fat loss, comparing Sculptra, Radiesse, a polyacrylamide filler and the patient's own fat over 24 months. Its authors concluded that permanent fillers and fat gave the most consistent results over time, which does not single out either product. The search did not return a trial showing that one gives better-looking cosmetic results than the other. In the studies cited here, the claim that one “makes more collagen” rests on manufacturer-funded or manufacturer-affiliated work.